HRP20181118T1 - Mjerenje autoprotutijela u uvjetima niske vodljivosti - Google Patents

Mjerenje autoprotutijela u uvjetima niske vodljivosti

Info

Publication number
HRP20181118T1
HRP20181118T1 HRP20181118TT HRP20181118T HRP20181118T1 HR P20181118 T1 HRP20181118 T1 HR P20181118T1 HR P20181118T T HRP20181118T T HR P20181118TT HR P20181118 T HRP20181118 T HR P20181118T HR P20181118 T1 HRP20181118 T1 HR P20181118T1
Authority
HR
Croatia
Prior art keywords
protibodies
auto
measurement
under low
low conductivity
Prior art date
Application number
HRP20181118TT
Other languages
English (en)
Croatian (hr)
Inventor
Alfred Weber
Andrea ENGELMAIER
Hans-Peter Schwarz
Original Assignee
Baxalta GmbH
Baxalta Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxalta GmbH, Baxalta Incorporated filed Critical Baxalta GmbH
Publication of HRP20181118T1 publication Critical patent/HRP20181118T1/hr

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4709Amyloid plaque core protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
HRP20181118TT 2011-12-13 2012-12-13 Mjerenje autoprotutijela u uvjetima niske vodljivosti HRP20181118T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161570211P 2011-12-13 2011-12-13
EP12820994.7A EP2791675B1 (en) 2011-12-13 2012-12-13 Measurement of autoantibodies in low conductivity conditions
PCT/US2012/069587 WO2013090636A1 (en) 2011-12-13 2012-12-13 Measurement of autoantibodies at low conductivity conditions with increased sensitivity

Publications (1)

Publication Number Publication Date
HRP20181118T1 true HRP20181118T1 (hr) 2018-09-21

Family

ID=47630506

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20181118TT HRP20181118T1 (hr) 2011-12-13 2012-12-13 Mjerenje autoprotutijela u uvjetima niske vodljivosti

Country Status (14)

Country Link
US (1) US9075069B2 (enExample)
EP (1) EP2791675B1 (enExample)
JP (1) JP6333731B2 (enExample)
KR (1) KR20140104479A (enExample)
AR (1) AR089233A1 (enExample)
AU (1) AU2012321074B2 (enExample)
DK (1) DK2791675T3 (enExample)
ES (1) ES2685332T3 (enExample)
HR (1) HRP20181118T1 (enExample)
HU (1) HUE038441T2 (enExample)
PL (1) PL2791675T3 (enExample)
PT (1) PT2791675T (enExample)
TW (1) TW201339578A (enExample)
WO (1) WO2013090636A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
EP3022225B1 (en) * 2013-07-19 2021-09-29 Board Of Regents Of the University Of Texas System Transthyretin amyloid-selective and polyreactive catabodies
SI24638A (sl) 2014-02-04 2015-08-31 Univerzitetni kliniÄŤni center Ljubljana Fluorometrična imunska metoda za določanje protiteles proti dvojnoverižni DNA
BR112017002575B1 (pt) * 2014-08-08 2023-11-07 Allegheny Singer Research Institute Método para diagnosticar especificamente lúpus sistêmico eritematoso em um indivíduo
JP6674543B2 (ja) 2015-07-31 2020-04-01 アレゲーニー・シンガー リサーチ インスティチュート 抗体に基づく薬物のコンパニオン診断としての細胞結合補体活性化産物アッセイ
KR20170108203A (ko) 2016-03-16 2017-09-27 주식회사 피플바이오 응집형-형성 폴리펩타이드의 응집형을 검출하는 방법
CN108169303B (zh) * 2017-12-07 2019-08-20 商丘师范学院 基于金属有机框架材料作为信号探针的核酸适配体电化学传感器
WO2020010009A1 (en) * 2018-07-02 2020-01-09 Siemens Healthcare Diagnostics Inc. Direct immunoassay measurement of autoantibodies
JP7268306B2 (ja) * 2018-08-31 2023-05-08 東洋紡株式会社 生体試料中の測定対象物質を免疫学的に測定する方法
JP7356128B2 (ja) * 2019-06-07 2023-10-04 慶應義塾 自己免疫疾患の検出剤となるタンパク質複合体、及びその使用
CN113759107A (zh) * 2021-08-18 2021-12-07 苏州立禾生物医学工程有限公司 生物素标记缓冲液

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4259207A (en) * 1979-09-19 1981-03-31 American Hospital Supply Corporation Suspending medium for immunologic reactions
JPS57182168A (en) * 1981-05-02 1982-11-09 Mitsubishi Chem Ind Ltd Immunochemical reagent
US5183735A (en) * 1989-02-27 1993-02-02 Reaads Medical Products, Inc. Method and diagnostic test kit for detection of anti-dsDNA antibodies
US5194585A (en) * 1989-04-25 1993-03-16 Igen, Inc. Inhibitors of catalytic antibodies
US5981180A (en) 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
US5763158A (en) 1997-02-06 1998-06-09 The United States Of America As Represented By The Secretary Of The Army Detection of multiple antigens or antibodies
US6958244B2 (en) * 2002-04-12 2005-10-25 Bruker Biospin Corp. Low-conductivity buffers for magnetic resonance measurements
WO2005027714A2 (en) * 2003-07-12 2005-03-31 Accelr8 Technology Corporation Sensitive and rapid biodetection
EP2522753B1 (en) 2007-08-13 2014-04-02 Baxter International Inc. IVIG modulation of chemokines for treatment of Multiple Sclerosis, Alzheimer's disease, and Parkinson's disease
US8852874B2 (en) 2008-02-29 2014-10-07 Baxter International Inc. Anti-amyloid β activity of intravenous immunoglobulin (IVIG) in vitro
EP2418486B1 (en) * 2009-03-05 2013-11-06 Denka Seiken Co., Ltd. Test reagent kit and its use in a method for measuring an analyte in test sample
TW201040529A (en) * 2009-03-31 2010-11-16 Japan Tobacco Inc Method for detecting antibody against SITH-1 in biological sample
BRPI1012082B1 (pt) 2009-05-27 2022-08-16 Takeda Pharmaceutical Company Limited Método para preparar uma composição de igg concentrada a partir de plasma
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield

Also Published As

Publication number Publication date
HUE038441T2 (hu) 2018-10-29
JP6333731B2 (ja) 2018-05-30
JP2015500502A (ja) 2015-01-05
KR20140104479A (ko) 2014-08-28
ES2685332T3 (es) 2018-10-08
PL2791675T3 (pl) 2018-10-31
EP2791675B1 (en) 2018-04-25
US20130149700A1 (en) 2013-06-13
EP2791675A1 (en) 2014-10-22
WO2013090636A1 (en) 2013-06-20
PT2791675T (pt) 2018-07-27
TW201339578A (zh) 2013-10-01
DK2791675T3 (da) 2018-07-30
US9075069B2 (en) 2015-07-07
AR089233A1 (es) 2014-08-06
AU2012321074A1 (en) 2013-06-27
AU2012321074B2 (en) 2015-12-03

Similar Documents

Publication Publication Date Title
EP3736578C0 (en) CURRENT MEASUREMENT
HRP20181118T1 (hr) Mjerenje autoprotutijela u uvjetima niske vodljivosti
PL2831279T3 (pl) Szybkie wykrywanie aneuploidii
DK2649468T3 (da) Ultralydsmåling
DK4049581T3 (da) Fjernmonitorering af analytmålinger
EP2675909A4 (en) GLUCOSYLSTEVIA COMPOSITION
EP2720561A4 (en) Stevia-COMPOSITION
EP2683693A4 (en) ROR-GAMMA-T INHIBITORS
EP2713762A4 (en) Stevia-COMPOSITION
EP2673344A4 (en) STABLE BIO OIL
BR112013027644A2 (pt) método de medição de conformação
DK3002135T3 (da) Bugseringsenhed
JP2011209285A5 (ja) 力測定システム
FR2975488B1 (fr) Capteur
NO343662B1 (no) Strømningsmåling
EP2744740A4 (en) BOOM STRUCTURE
EP2661633A4 (en) PROOF OF PROTEOLYSIS
PT2793883T (pt) Antagonistas de trpm8
FI20116329L (fi) Mittauskohteen mittaus
EP2795304A4 (en) ELECTROCHEMICAL SENSORS
BR112013032459A2 (pt) indicação de material estranho
HRP20182057T1 (hr) Temperaturno stabilni vodeni pripravci klokintocet-meksila
BR112013029333A2 (pt) detecção de nível
FI20115209L (fi) Huokoisuusmittaus
DK3043589T3 (da) Målerapportering